Sarepta Therapeutics SRPT
NASDAQ SRPT
$16.48 +0.06 (+0.37%)
As of: Nov 11, 2026 · 12:27 PM EST

Sarepta Therapeutics (SRPT) Change in Account Payables (2025 - 2026)

Updated

Sarepta Therapeutics' Change in Account Payables came in at -$19.39 million for Q2 2026, compared with -$19.4 million a year earlier.

Analysis

Sarepta Therapeutics (SRPT) Change in Account Payables (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Sarepta Therapeutics reported Change in Account Payables of -$307.6 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 83.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 254.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Sarepta Therapeutics 1.76 Bn -1.50 Bn 192.84 Mn -6.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -6.71 Mn
Jun 30, 2026 -19.39 Mn
Mar 31, 2026 -210.47 Mn
Sep 30, 2025 -12.12 Mn
Jun 30, 2025 -19.40 Mn
Mar 31, 2025 -58.34 Mn
API Access

Sarepta Therapeutics Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=SRPT&period=max&api_key=YOUR_API_KEY